Aepodia Competitors and Similar CompaniesClear all
Aepodia's competitors and similar companies include GSK, Eolo Pharma, Visus Therapeutics and Novartis France.
 Aepodia Aepodia is a company specialized in the strategy and delivery of drugs and the development of medical devices. |  GSK GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. |  Eolo Pharma EOLO Pharma is a company that focuses on developing drugs targeting the molecular and cellular basis of inflammation-related diseases (e.g. type II diabetes, autoimmune, metabolic syndrome, hypertension, atherosclerosis, etc.) |  Novartis France Novartis France (also known as Novartis Pharma) is a company developing medical treatments. | ||
Founding Date | Founding Date 2007 | Founding Date 2000 | Founding Date 2017 | Founding Date 2019 | Founding Date 1997 |
Type | Type Private | Type Public | Type Private | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations Ottignies-Louvain-la-Neuve, BE HQ Villebon Sur Yvette, FR | Locations London, GB HQ Boumerdes, DZ Buenos Aires, AR Abbotsford, AU Wien, AT Wavre, BE Rio De Janeiro, BR see more | Locations HQ | Locations Seattle, US HQ Irvine, US | Locations Rueil-Malmaison, FR HQ |
Employees | Employees 6 | Employees 68,629 | Employees N/A | Employees 645% increase | Employees 5282% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) £32.7b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) €2.3b (FY, 2021) |
Cost of goods | Cost of goods N/A | Cost of goods £5.6b (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods €1.4b (FY, 2021) |
Gross profit | Gross profit N/A | Gross profit £28.5b (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit €844.1m (FY, 2021) |
Net income | Net income N/A | Net income £6.3b (FY, 2025) | Net income N/A | Net income N/A | Net income €47m (FY, 2021) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 2.7m (over 6 years ago) | Latest funding round $ 20m (over 4 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 2.7m | Total funding raised $ 56m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
GSK
HQ
London, GB
Employees
68,629
GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products.
View companyEolo Pharma
HQ
EOLO Pharma is a company that focuses on developing drugs targeting the molecular and cellular basis of inflammation-related diseases (e.g. type II diabetes, autoimmune, metabolic syndrome, hypertension, atherosclerosis, etc.)
View company
Visus Therapeutics
HQ
Seattle, US
Employees
64↑ 5% increase
Visus Therapeutics is a clinical-stage pharmaceutical company.
View companyNovartis France
HQ
Rueil-Malmaison, FR
Novartis France (also known as Novartis Pharma) is a company developing medical treatments.
View company